Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
A rapid and versatile method for the isolation, purification and cryogenic storage of Schwann cells from adult rodent nerves.
Inflammatory demyelinating neuropathy heralding accelerated Chediak-Higashi syndrome.
Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.
Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.
Self-reported levels of education and disability progression in multiple sclerosis.
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.
Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.
Smoking as a risk factor for developing Multiple Sclerosis: A meta-analysis of observational studies.
Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.
Mutism Caused by Severe Demyelination in a Patient With Marchiafava-Bignami Disease.
[Anti-NMDA Receptor Antibody-Related Encephalitis].
Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis.
Central pontine myelinolysis caused by hypernatremia.
N98S mutation in NEFL gene is dominantly inherited with a phenotype of polyneuropathy and cerebellar atrophy.
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids.
Clinical Profile of Patients Requiring Prolonged Mechanical Ventilation and their Outcome in a Tertiary Care Medical ICU.
Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis.
Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
Isolated pure verbal amnesia as the disease onset of probable multiple sclerosis with a left forniceal black hole.
Pages
« first
‹ previous
…
790
791
792
793
794
795
796
797
798
…
next ›
last »